Literature DB >> 24676638

When erythropoietin meddles in immune affairs.

Frank Martinez1, Nicolas Pallet2.   

Abstract

Entities:  

Keywords:  Immunology and pathology; erythropoietin; immunosuppression

Mesh:

Substances:

Year:  2014        PMID: 24676638      PMCID: PMC4147992          DOI: 10.1681/ASN.2014030240

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  25 in total

1.  The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor.

Authors:  P T Jubinsky; O I Krijanovski; D G Nathan; J Tavernier; C A Sieff
Journal:  Blood       Date:  1997-09-01       Impact factor: 22.113

2.  Purification of human erythropoietin.

Authors:  T Miyake; C K Kung; E Goldwasser
Journal:  J Biol Chem       Date:  1977-08-10       Impact factor: 5.157

3.  Correction of anemia with epoetin alfa in chronic kidney disease.

Authors:  Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

4.  Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.

Authors:  J P Kaltwasser; U Kessler; R Gottschalk; G Stucki; B Möller
Journal:  J Rheumatol       Date:  2001-11       Impact factor: 4.666

5.  Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells.

Authors:  S Masuda; M Nagao; K Takahata; Y Konishi; F Gallyas; T Tabira; R Sasaki
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

6.  Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

Authors:  J W Eschbach; J C Egrie; M R Downing; J K Browne; J W Adamson
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

7.  Isolation and characterization of genomic and cDNA clones of human erythropoietin.

Authors:  K Jacobs; C Shoemaker; R Rudersdorf; S D Neill; R J Kaufman; A Mufson; J Seehra; S S Jones; R Hewick; E F Fritsch
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

8.  Carbamylated erythropoietin improves angiogenesis and protects the kidneys from ischemia-reperfusion injury.

Authors:  Ryoichi Imamura; Masayoshi Okumi; Yoshitaka Isaka; Naotsugu Ichimaru; Toshiki Moriyama; Enyu Imai; Norio Nonomura; Shiro Takahara; Akihiko Okuyama
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

Review 9.  Erythropoietin: physiology and pharmacology update.

Authors:  James W Fisher
Journal:  Exp Biol Med (Maywood)       Date:  2003-01

10.  Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE.

Authors:  RuiRong Yuan; Yasuhiro Maeda; Weiping Li; Wei Lu; Stuart Cook; Peter Dowling
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

View more
  3 in total

1.  B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy.

Authors:  Takayuki Yamamoto; Qi Li; Hidetaka Hara; Liaoran Wang; Hongmin Zhou; Juan Li; Devin E Eckhoff; A Joseph Tector; Edwin C Klein; Ray Lovingood; Mohamed Ezzelarab; David Ayares; Yi Wang; David K C Cooper; Hayato Iwase
Journal:  Transpl Immunol       Date:  2018-08-06       Impact factor: 1.708

2.  Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts.

Authors:  Hayato Iwase; Hidetaka Hara; Mohamed Ezzelarab; Tao Li; Zhongqiang Zhang; Bingsi Gao; Hong Liu; Cassandra Long; Yi Wang; Amy Cassano; Edwin Klein; Carol Phelps; David Ayares; Abhinav Humar; Martin Wijkstrom; David K C Cooper
Journal:  Xenotransplantation       Date:  2017-03-17       Impact factor: 3.907

Review 3.  Immune Dysfunction in Uremia 2020.

Authors:  Gerald Cohen
Journal:  Toxins (Basel)       Date:  2020-07-05       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.